Australia
· Delayed Price · Currency is AUD Clarity Pharmaceuticals Statistics
Total Valuation
ASX:CU6 has a market cap or net worth of AUD 713.40 million. The enterprise value is 602.21 million.
| Market Cap | 713.40M |
| Enterprise Value | 602.21M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CU6 has 321.35 million shares outstanding. The number of shares has increased by 15.21% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 321.35M |
| Shares Change (YoY) | +15.21% |
| Shares Change (QoQ) | +11.53% |
| Owned by Insiders (%) | 17.78% |
| Owned by Institutions (%) | 13.58% |
| Float | 225.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.96 |
| PB Ratio | 5.59 |
| P/TBV Ratio | 5.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.36 |
| EV / Sales | 55.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.81 |
Financial Position
The company has a current ratio of 14.55
| Current Ratio | 14.55 |
| Quick Ratio | 13.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.99% and return on invested capital (ROIC) is -39.07%.
| Return on Equity (ROE) | -53.99% |
| Return on Assets (ROA) | -36.11% |
| Return on Invested Capital (ROIC) | -39.07% |
| Return on Capital Employed (ROCE) | -44.17% |
| Revenue Per Employee | 215,536 |
| Profits Per Employee | -974,066 |
| Employee Count | 50 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.83% in the last 52 weeks. The beta is 1.62, so ASX:CU6's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -21.83% |
| 50-Day Moving Average | 3.27 |
| 200-Day Moving Average | 5.46 |
| Relative Strength Index (RSI) | 28.90 |
| Average Volume (20 Days) | 2,732,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CU6 had revenue of AUD 10.78 million and -48.70 million in losses. Loss per share was -0.16.
| Revenue | 10.78M |
| Gross Profit | 10.78M |
| Operating Income | -56.39M |
| Pretax Income | -48.47M |
| Net Income | -48.70M |
| EBITDA | -56.21M |
| EBIT | -56.39M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 111.19 million in cash and n/a in debt, giving a net cash position of 111.19 million or 0.35 per share.
| Cash & Cash Equivalents | 111.19M |
| Total Debt | n/a |
| Net Cash | 111.19M |
| Net Cash Per Share | 0.35 |
| Equity (Book Value) | 127.35M |
| Book Value Per Share | 0.40 |
| Working Capital | 127.10M |
Cash Flow
In the last 12 months, operating cash flow was -46.84 million and capital expenditures -166,614, giving a free cash flow of -47.01 million.
| Operating Cash Flow | -46.84M |
| Capital Expenditures | -166,614 |
| Free Cash Flow | -47.01M |
| FCF Per Share | -0.15 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -523.30% |
| Pretax Margin | -449.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:CU6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.21% |
| Shareholder Yield | -15.21% |
| Earnings Yield | -6.83% |
| FCF Yield | -6.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:CU6 has an Altman Z-Score of 92.26.
| Altman Z-Score | 92.26 |
| Piotroski F-Score | n/a |